Brief: Independent Data, Safety Monitoring Board Recommends CytoSorbents To Continue STAR-T Trial Without Modifications

Cytosorbents

21/12/2022 12:24

Dec 21 (Reuters) - CytoSorbents Corp  CTSO.O :
    * CYTOSORBENTS RECEIVES RECOMMENDATION FROM INDEPENDENT DATA
AND
SAFETY MONITORING BOARD TO CONTINUE PIVOTAL STAR-T TRIAL AS
PLANNED WITHOUT MODIFICATIONS
    * CYTOSORBENTS CORP- GOAL OF ACHIEVING NEXT MILESTONE OF 80
PATIENTS ENROLLED BY SPRING 2023

Source text for Eikon:  ID:nPn2Kxmgja 
Further company coverage:  CTSO.O 
 ((Reuters.Briefs@thomsonreuters.com;))